Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
09/2003
09/24/2003CN1443557A Yigante capsule for curing hepatitis B
09/24/2003CN1443538A Medicine preparation for inhibiting immune deficiency syndrome virus infection and proliferation and its application
09/24/2003CN1122105C Novel method viruses, anti viral compounds and novel methods of making vaccines
09/24/2003CN1122040C Suger modified nucleosides and their use of synthesis of oligonucleotide
09/24/2003CN1122037C Thiophene [2,3,-d] hybar X compound and its preparing method, use and medical composition containing it
09/24/2003CN1121871C Chinese medicinal skin disinfectant
09/24/2003CN1121860C Antifungal composition with enhanced bioavailability
09/24/2003CN1121857C Use of gamma RAR specific agonist ligand to increase apoptosis rate
09/23/2003US6624292 Methylation of erythromycin A followed by slurrying with water
09/23/2003US6624199 Prophylaxis and treatment of acne and acne related skin diseases with aminobenzophenones, and novel compounds effective in the treatment, as well as pharmaceutical preparations containing these compounds and dosage units
09/23/2003US6624184 Amide and diamide inhibitors of IMPDH enzyme for use in treating IMPDH-associated disorders
09/23/2003US6624172 Imidazonaphthyridines
09/23/2003US6624168 Bactericides, bacteriostats
09/23/2003US6624167 Compounds that are capable of affecting nicotinic cholinergic receptors. A wide variety of conditions and disorders, and particularly conditions and disorders associated with dysfunction of the central and autonomic nervous systems can
09/23/2003US6624160 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents
09/23/2003US6624159 Herpes virus
09/23/2003US6624157 Antitumor agents
09/23/2003US6624143 Calcium salts of lipopeptide antibiotics, method for producing same and their use
09/23/2003US6624140 Synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome
09/23/2003US6623951 HBV vectors and cells for producing the same
09/23/2003US6623767 Mixture containing honey, at least one essential oil and/or at least one essential oil derivative
09/23/2003US6623757 Mixture of antibiotics; variations of releasing profiles
09/23/2003US6623753 Allylamine-containing liposomes
09/23/2003US6623741 Methods and compositions for inhibition of membrane fusion-associated events including RSV transmission
09/23/2003CA2164818C Tandem synthetic hiv-1 peptides
09/23/2003CA2074385C Pleuromutilin complexes
09/21/2003CA2422623A1 Microdialysis methods and applications for treatment and/or prophylaxis of tumors and/or infections in the central nervous system (cns) and/or in other parenchymal organs
09/18/2003WO2003076602A2 Use of l-$g(a)-lysophosphatidycholine to obtain the differentiation of monocytes in mature dendritric cells in vivo
09/18/2003WO2003076591A2 Compositions and methods for generating an immune response
09/18/2003WO2003076565A2 Methods of using 46828, a human acyl-coa synthetase
09/18/2003WO2003076471A2 A multifunctional complex for targeting specific phagocytosis of a target agent
09/18/2003WO2003076470A1 Monoclonal and polyclonal antibodies recognizing coagulase-negative staphylococcal proteins
09/18/2003WO2003076468A1 Novel therapeutic composition for the prevention and treatment of hiv-1 infection in humans
09/18/2003WO2003076460A1 A process for the production of ramoplanin-like amide derivatives
09/18/2003WO2003076447A1 An optically acitve pyridine derivative and a medicament containing the same
09/18/2003WO2003076441A1 Pyrazolopyrimidine and pyrazolotriazine derivatives and pharmaceutical compositions containing them
09/18/2003WO2003076438A1 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076437A1 Cdk inhibiting 2-heteroaryl pyrimidine, the production thereof, and use thereof as a medicament
09/18/2003WO2003076430A1 Amino-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076428A1 Quinolonecarboxylic acid derivative
09/18/2003WO2003076424A1 Macrocyclic compounds useful as pharmaceuticals
09/18/2003WO2003076421A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076413A1 Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
09/18/2003WO2003076407A1 Novel chalcone derivatives and uses thereof
09/18/2003WO2003076400A1 New inhibitors of histone deacetylase
09/18/2003WO2003075956A2 Use of mixtures of lipopeptides for vaccine production
09/18/2003WO2003075954A1 Fuel additive
09/18/2003WO2003075929A1 Inhibitors of histone deacetylase
09/18/2003WO2003075923A1 Vdac regulator
09/18/2003WO2003075907A2 Small molecule entry inhibitors
09/18/2003WO2003075895A1 Tasted masked veterinary solid compositions
09/18/2003WO2003075891A1 Dispersed solid-containing complex carbohydrate
09/18/2003WO2003075890A1 Methods for entrapment of bioactive agent in a liposome or lipid complex
09/18/2003WO2003075889A1 An inhalation system for prevention and treatment of intracellular infections
09/18/2003WO2003075857A2 Amino-methyl substituted tetracycline compounds
09/18/2003WO2003075852A2 Antibiotic composition
09/18/2003WO2003075843A2 Multiple and multivalent dna vaccines in ovo
09/18/2003WO2003075834A2 Activated protein c formulations
09/18/2003WO2003075833A2 Screening method for orthopoxvirus antivirals
09/18/2003WO2003075825A2 The method of treating tuberculosis
09/18/2003WO2003075824A2 Process of manufacturing pharmaceutical composition useful for management of tuberculosis
09/18/2003WO2003075788A2 Biodegradable microbicidal vaginal barrier device
09/18/2003WO2003075685A2 Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof
09/18/2003WO2003075676A1 Probiotic delivery system
09/18/2003WO2003075670A1 Treatment and prevention of inflammatory disorders
09/18/2003WO2003075654A2 Treatment of surfaces populated by bacteria with a lucilia sericata extract
09/18/2003WO2003059252A3 Use of a novel cell surface protease from group b streptococcus
09/18/2003WO2003053915A3 Compounds for the treatment of inflammatory disorders
09/18/2003WO2003051893A3 Improvements in pharmaceutical compositions
09/18/2003WO2003051807A3 Improvements in pharmaceutical compositions
09/18/2003WO2003046135A3 Osteopontin-related compositions and methods
09/18/2003WO2003037310A3 Use of inhibitors of the abc drug transporter to increase the activity of anti-microbial agents
09/18/2003WO2003032928A3 Therapeutic composition and use
09/18/2003WO2003008441A3 Moringa seed proteins
09/18/2003WO2002094868A3 Staphylococcus aureus proteins and nucleic acids
09/18/2003WO2002092136A3 Immunoconjugates made of egg-yolk antibodies (igy), production and use thereof in diagnoses and therapy
09/18/2003WO2002080982A3 Nucleic acid mucosal immunization
09/18/2003WO2002078627A3 N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity
09/18/2003WO2002077174A3 Human cytokine receptor
09/18/2003WO2002072790A3 Tsg101-gag interaction and use thereof
09/18/2003WO2002066646A3 Neurotransmission-associated proteins
09/18/2003WO2002062750A9 Cannabinoid receptor ligands
09/18/2003WO2002059308A3 Method of diagnosing and treating cartilage disorders
09/18/2003WO2002050287A3 Multifunctional protease inhibitors and their use in treatment of disease
09/18/2003WO2002036625A9 Prokineticin polypeptides, related compositions and methods
09/18/2003WO2002036110A9 Oral self-emulsifying formulations of pyranone protease inhibitors
09/18/2003WO2002034745A8 Chemokine receptor binding heterocyclic compounds
09/18/2003WO2002000687A9 Antimicrobial peptides and methods of use thereof
09/18/2003US20030176686 Diagnosis, therapy; animal growth regulators; controlling cell differentiation; antiiinflammatory agents, antihistamines, Crohn's disease, anticancer agents, autoimmune disease
09/18/2003US20030176670 Multivalent macrolide antibiotics
09/18/2003US20030176668 C-nitroso compounds and use thereof
09/18/2003US20030176653 Orally immunogenic bacterial enterotoxins expressed in transgenic plants
09/18/2003US20030176650 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof
09/18/2003US20030176642 Peptoid and nonpeptoid containing alpha-keto oxadiazoles as serine protease inhibitors
09/18/2003US20030176500 Medium chain fatty acids applicable as antimicrobial agents
09/18/2003US20030176497 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments
09/18/2003US20030176495 HIV Integrase inhibitors
09/18/2003US20030176491 For therapy and prophylaxis of prostatitis or interstitial cystitis, inflammatory bowel disease, Crohn's disease, ulcerative proctitis, or colitis, prostatic hypertrophy, uterine leiomyomas, breast cancer, endometrial cancer
09/18/2003US20030176486 For use as an inhibitor of lipopolysaccharides (LPS)
09/18/2003US20030176480 Amide-type triazole compounds
1 ... 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 ... 1798